Surgery Partners (SGRY) Moves 7.7% Higher: Will This Strength Last?

Core Viewpoint - Surgery Partners (SGRY) shares experienced a significant increase of 7.7% to $15, following a period of 13.4% loss over the past four weeks, indicating a potential turnaround in investor sentiment [1][2]. Financial Performance Expectations - The company is anticipated to report fourth quarter 2025 revenues of $873.54 million, reflecting a year-over-year increase of 1.1% [3]. - Earnings per share (EPS) for the upcoming quarter is projected at $0.31, which represents a year-over-year decline of 29.6% [3]. Market Sentiment and Stock Movement - The recent price increase is attributed to investor optimism regarding the upcoming financial results, despite the lack of changes in earnings estimate revisions over the past 30 days [2][4]. - The stock currently holds a Zacks Rank of 3 (Hold), suggesting a neutral outlook in the short term [4]. Industry Context - Surgery Partners operates within the Zacks Medical Services industry, which includes other companies like Natera (NTRA), that has seen a decline of 11% over the past month [4]. - Natera's EPS estimate has decreased by 3.3% over the past month, indicating potential challenges within the same industry [5].